Results 71 to 80 of about 2,265,539 (159)

Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats

Proceedings of the National Academy of Sciences of the United States of America, 2002
J. Horváth, A. Bajo, A. Schally, M. Kovács, F. Herbert, K. Groot   +5 more
semanticscholar   +1 more source

Peptide Aptamer-Paclitaxel Conjugates for Tumor Targeted Therapy. [PDF]

Pharmaceutics
Shen X, Ma Y, Luo H, Abdullah R, Pan Y, Zhang Y, Zhong C, Zhang B, Zhang G.   +8 more
europepmc   +1 more source

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver. [PDF]

J Clin Invest
Tang DG.
europepmc   +1 more source

Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly. [PDF]

Pituitary
Mitsui Y, Mukai K, Otsuki M, Oshino S, Saitoh Y, Kohara M, Morii E, Fukuhara A, Shimomura I.   +8 more
europepmc   +1 more source

The past and present of prostate cancer and its treatment and diagnostics: A historical review. [PDF]

SAGE Open Med, 2023
Lehtonen M, Kellokumpu-Lehtinen PL.
europepmc   +1 more source

Concomitant Administration of Psychotropic and Prostate Cancer Drugs: A Pharmacoepidemiologic Study Using Drug-Drug Interaction Databases. [PDF]

Biomedicines
Ungureanu D, Popa A, Nemeș A, Crișan CA.   +3 more
europepmc   +1 more source

Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer. [PDF]

Mater Today Bio
Qiao JX, Guo DY, Tian H, Wang ZP, Fan QQ, Tian Y, Sun J, Zhang XF, Zou JB, Cheng JX, Luan F, Zhai BT.   +11 more
europepmc   +1 more source

CAMBRIA-1 & CAMBRIA-2 phase III trials: camizestrant versus standard endocrine therapy in ER+/HER2- early breast cancer. [PDF]

Future Oncol
Hamilton EP, Loibl S, Bachelot T, Gnant M, Niikura N, Park YH, Tolaney SM, Pistilli B, Rastogi P, Saini KS, Gioni I, Johnston S, Nunes R, Quintana A, Stuart M, Syta E, Walding A, Klinowska T, Mayer IA.   +18 more
europepmc   +1 more source

Endocrine treatment mechanisms in triple-positive breast cancer: from targeted therapies to advances in precision medicine. [PDF]

Front Oncol
Yang X, Yang D, Qi X, Luo X, Zhang G.
europepmc   +1 more source

Gilteritinib-Induced Hypopituitarism: A Case Report. [PDF]

Cureus
Hori Y, Okada Y, Sonoda S, Torimoto K, Tanaka Y.   +4 more
europepmc   +1 more source